# Kronos Bio, Inc.

Kronos Bio, Inc. is a company headquartered in San Mateo, CA, United States.

## Company overview

- **Legal name:** Kronos Bio, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Mateo, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001741830

## About

Kronos Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001741830, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-18, it reported annual revenue of USD 9,848,000; net income of USD -86,079,000; total assets of USD 124,363,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $9.8M (USD 9,848,000)
- **Net income:** -$86.1M (USD -86,079,000)
- **Total assets:** $124.4M (USD 124,363,000)
- **Cash and equivalents:** $84.6M (USD 84,571,000)
- **Operating cash flow:** -$65.4M (USD -65,435,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $6.3M (USD 6,288,000)
- **Net income:** -$112.7M (USD -112,673,000)
- **Total assets:** $213.3M (USD 213,279,000)
- **Cash and equivalents:** $64.3M (USD 64,326,000)
- **Operating cash flow:** -$78.6M (USD -78,582,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$133.2M (USD -133,204,000)
- **Total assets:** $294.9M (USD 294,938,000)
- **Cash and equivalents:** $76.0M (USD 75,973,000)
- **Operating cash flow:** -$90.9M (USD -90,926,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$151.1M (USD -151,078,000)
- **Total assets:** $391.5M (USD 391,476,000)
- **Cash and equivalents:** $198.3M (USD 198,270,000)
- **Operating cash flow:** -$117.9M (USD -117,924,000)

## Recent SEC filings

- Form 8-K — filed 2025-06-20 — period 2025-06-20 — CURRENT REPORT
- Form 8-K — filed 2025-06-05 — period 2025-06-04 — CURRENT REPORT
- Form 10-Q — filed 2025-05-08 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-01 — period 2025-05-01 — CURRENT REPORT
- Form 10-K/A — filed 2025-04-25 — period 2024-12-31 — 10-K/A
- Form 8-K — filed 2025-04-10 — period 2025-04-08 — 8-K
- Form 10-K — filed 2025-03-18 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-18 — period 2025-03-18 — 8-K
- Form 8-K — filed 2024-12-27 — period 2024-12-20 — 8-K
- Form 8-K — filed 2024-11-27 — period 2024-11-22 — 8-K
- Form 10-Q — filed 2024-11-13 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-11-13 — period 2024-11-13 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/kronos-bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology